SOX10 and breast cancer: In addition to regulating cell survival and promoting tumor growth, we have shown that AKT controls the expression of Sox10. Therefore, we believe that the therapeutic targeting of AKT could decrease mammary tumor stem/progenitor activity by downregulating SOX10 expression in TNBC.